Italia -
italiano -
AIFA (Agenzia Italiana del Farmaco)
triasporin
italfarmaco s.p.a. - itraconazolo - itraconazolo
Italia -
italiano -
AIFA (Agenzia Italiana del Farmaco)
itraconazolo sandoz
sandoz s.p.a. - itraconazolo - itraconazolo
Italia -
italiano -
AIFA (Agenzia Italiana del Farmaco)
itraconazolo sandoz gmbh
sandoz gmbh - itraconazolo - itraconazolo
Svizzera -
italiano -
Swissmedic (Swiss Agency for Therapeutic Products)
trixeo aerosphere 5/7.2/160 μg druckgasinhalation, suspension
astrazeneca ag - budesonidum, glycopyrronium, formoteroli fumaras dihydricus - druckgasinhalation, suspension - budesonidum 160 µg, glycopyrronii bromidum 9 µg corresp. glycopyrronium 7.2 µg, formoteroli fumaras dihydricus 5 µg, 1,2-distearoyl-sn-glycero-3-phosphocholinum, calcii chloridum dihydricum, norfluranum, ad suspensionem pro dosi. - bpco - synthetika
Svizzera -
italiano -
Swissmedic (Swiss Agency for Therapeutic Products)
jorveza 1 mg compresse orodispersibili
dr. falk pharma ag - budesonidum - compresse orodispersibili - budesonidum 1 mg, dinatrii citras sesquihydricus, natrii dihydrogenocitras anhydricus, natrii hydrogenocarbonas, sucralosum, povidonum k 25, natrii docusas, mannitolum, macrogolum 6000, magnesii stearas pro compresso corresp. natrium 25.62 mg. - bei erwachsenen zur behandlung der eosinophilen Ösophagitis (eoÖ) - synthetika
Svizzera -
italiano -
Swissmedic (Swiss Agency for Therapeutic Products)
jorveza 0.5 mg compresse orodispersibili
dr. falk pharma ag - budesonidum - compresse orodispersibili - budesonidum 0.5 mg, dinatrii citras sesquihydricus, natrii dihydrogenocitras anhydricus, natrii hydrogenocarbonas, sucralosum, povidonum k 25, natrii docusas, mannitolum, macrogolum 6000, magnesii stearas pro compresso corresp. natrium 25.62 mg. - bei erwachsenen zur behandlung der eosinophilen Ösophagitis (eoÖ) - synthetika
Svizzera -
italiano -
Swissmedic (Swiss Agency for Therapeutic Products)
entocort enema clistere
tillotts pharma ag - budesonidum - clistere - i) dispergierbare tablette: budesonidum 2.3 mg, lactosum, riboflavini natrii phosphas, crospovidonum, silica colloidalis anhydrica, magnesii stearas pro compresso. ii) vehikel: e 218 80 mg, propylis parahydroxybenzoas 20 mg, natrii chloridum, aqua purificata ad solutionem pro 100 ml. suspensio reconstituta: budesonidum 2 mg, lactosum, riboflavini natrii phosphas, crospovidonum, silica colloidalis anhydrica, magnesii stearas, e 218 80 mg, propylis parahydroxybenzoas 20 mg, natrii chloridum, aqua purificata ad suspensionem pro 100 ml. - la colite ulcerosa - synthetika
Svizzera -
italiano -
Swissmedic (Swiss Agency for Therapeutic Products)
budenofalk 3 mg capsule
dr. falk pharma ag - budesonidum - capsule - budesonidum 3 mg, sacchari sphaerae corresp. saccharum 276 mg et maydis amylum, lactosum monohydricum 12 mg, povidonum k 25, acidi methacrylici et methylis methacrylatis polymerisatum 1:1, acidi methacrylici et methylis methacrylatis polymerisatum 1:2, ammonio methacrylatis copolymerum b, ammonio methacrylatis copolymerum a, triethylis citras, talcum, kapselhülle: gelatina, e 172 (rubrum), e 171, e 127, e 172 (nigrum), natrii laurilsulfas corresp. natrium 0.006 mg, pro capsula. - morbus chron, kollagene colitis - synthetika
Svizzera -
italiano -
Swissmedic (Swiss Agency for Therapeutic Products)
cortinasal 50 nasenspray, suspension
spirig healthcare ag - budesonidum - nasenspray, suspension - budesonidum 50 µg, glucosum, cellulosum microcristallinum et carmellosum natricum, e 202 60 µg, polysorbatum 80, dinatrii edetas, acidum hydrochloridum, aqua purificata ad suspensionem pro dosi. doses pro vase 200. - la rinite - synthetika
Svizzera -
italiano -
Swissmedic (Swiss Agency for Therapeutic Products)
cortinasal 100 nasenspray, suspension
spirig healthcare ag - budesonidum - nasenspray, suspension - budesonidum 100 µg, glucosum, cellulosum microcristallinum et carmellosum natricum, e 202 60 µg, polysorbatum 80, dinatrii edetas, acidum hydrochloridum, aqua purificata ad suspensionem pro dosi. doses pro vase 200. - la rinite - synthetika